PRECIGEN, INC. Stock Issued During Period, Shares, Other
PRECIGEN, INC. (PGEN) reported Stock Issued During Period, Shares, Other of 7.48 million shares for the 9-month period ending 2018-09-30, per its 10-Q filed 2019-11-12.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesOther · last filed 2026-03-25
- 2018-09-30: Stock Issued During Period, Shares, Other 9 month 7.48M shares.
- 2018-07-31: Stock Issued During Period, Shares, Other 1 month 7.48M shares.
| Period end | Stock Issued During Period, Shares, Other 1 month | Stock Issued During Period, Shares, Other 9 month |
|---|---|---|
| 2018-09-30 | 7.48M shares 10-Q · filed 2019-11-12 | |
| 2018-07-31 | 7.48M shares 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |